The Safety of Linagliptin vs. Other Antidiabetic Agents with Regard to the Risk of Heart Failure Hospitalization in Routine Care in the U.S.
Keyword(s):
2021 ◽
Vol 22
(Supplement_1)
◽
2021 ◽
Vol 77
(18)
◽
pp. 791
2011 ◽
Vol 124
(9)
◽
pp. 834-840
◽
2015 ◽
Vol 65
(10)
◽
pp. A1003
2011 ◽
Vol 174
(6)
◽
pp. 672-680
◽
Keyword(s):